🇺🇸 FDA
Patent

US 11357759

Composition including ADAM9 inhibitor and the use thereof

granted A61KA61K31/427A61K31/4439

Quick answer

US patent 11357759 (Composition including ADAM9 inhibitor and the use thereof) held by China Medical University expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/427, A61K31/4439, A61K31/454, A61K31/4709